Seeking Alpha

Momenta Pharmaceuticals (MNTA) says the U.S. Court of Appeals has issued its opinion supporting...

Momenta Pharmaceuticals (MNTA) says the U.S. Court of Appeals has issued its opinion supporting its previous decision to stay the preliminary injunction in the case against Amphastar Pharmaceuticals, Watson Pharmaceuticals (WPI) and International Medical Systems. MNTA CEO Craig Wheeler notes the opinion is a setback for the company and has "potentially wide ranging implications for all patent holders." Shares +3.6% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector